246 related articles for article (PubMed ID: 20875094)
1. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.
Hayashi M; Inoue Y; Komeda K; Shimizu T; Asakuma M; Hirokawa F; Miyamoto Y; Okuda J; Takeshita A; Shibayama Y; Tanigawa N
BMC Surg; 2010 Sep; 10():27. PubMed ID: 20875094
[TBL] [Abstract][Full Text] [Related]
2. Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis.
Bredt LC; Rachid AF
World J Surg Oncol; 2014 Dec; 12():391. PubMed ID: 25528650
[TBL] [Abstract][Full Text] [Related]
3. Resection margin with anatomic or nonanatomic hepatectomy for liver metastasis from colorectal cancer.
Inoue Y; Hayashi M; Komeda K; Masubuchi S; Yamamoto M; Yamana H; Kayano H; Shimizu T; Asakuma M; Hirokawa F; Miyamoto Y; Takeshita A; Shibayama Y; Uchiyama K
J Gastrointest Surg; 2012 Jun; 16(6):1171-80. PubMed ID: 22370732
[TBL] [Abstract][Full Text] [Related]
4. A new strategy with a grading system for liver metastases from colorectal cancer.
Komeda K; Hayashi M; Inoue Y; Shimizu T; Asakuma M; Hirokawa F; Miyamoto Y; Uchiyama K
Hepatogastroenterology; 2015; 62(137):111-7. PubMed ID: 25911879
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
[TBL] [Abstract][Full Text] [Related]
6. Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001).
Ozawa M; Watanabe J; Ishibe A; Goto K; Fujii Y; Nakagawa K; Suwa Y; Suwa H; Masui H; Sugita M; Mochizuki Y; Yamagishi S; Hasegawa S; Homma Y; Momiyama M; Kumamoto T; Matsuyama R; Takeda K; Taguri M; Endo I
Cancer Chemother Pharmacol; 2024 Jun; 93(6):565-573. PubMed ID: 38374403
[TBL] [Abstract][Full Text] [Related]
7. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
[TBL] [Abstract][Full Text] [Related]
8. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P
Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210
[TBL] [Abstract][Full Text] [Related]
9. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
Reddy SK; Tsung A; Marsh JW; Geller DA
J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic lymphatic invasion but not vascular invasion is a major prognostic factor after resection of colorectal cancer liver metastases.
Lupinacci RM; Mello ES; Pinheiro RS; Marques G; Coelho FF; Kruger JA; Perini MV; Herman P
World J Surg; 2014 Aug; 38(8):2089-96. PubMed ID: 24663482
[TBL] [Abstract][Full Text] [Related]
11. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.
Yamada H; Kondo S; Okushiba S; Morikawa T; Katoh H
World J Surg; 2001 Sep; 25(9):1129-33. PubMed ID: 11571947
[TBL] [Abstract][Full Text] [Related]
12. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.
de Jong MC; Pulitano C; Ribero D; Strub J; Mentha G; Schulick RD; Choti MA; Aldrighetti L; Capussotti L; Pawlik TM
Ann Surg; 2009 Sep; 250(3):440-8. PubMed ID: 19730175
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients.
Hashimoto M; Kobayashi T; Ishiyama K; Ide K; Ohira M; Tahara H; Kuroda S; Hamaoka M; Iwako H; Okimoto M; Ohdan H
Int J Surg; 2016 Dec; 36(Pt A):96-103. PubMed ID: 27741421
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.
Kato T; Yasui K; Hirai T; Kanemitsu Y; Mori T; Sugihara K; Mochizuki H; Yamamoto J
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S22-31. PubMed ID: 14530655
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of oncologic prognostic factors in the decision-making of pre-hepatectomy chemotherapy for colorectal cancer hepatic metastasis: the priority of hepatectomy.
Chan KM; Wu TH; Wang YC; Lee CF; Wu TJ; Chou HS; Lee WC; Chiang JM; Chen JS
World J Surg Oncol; 2018 Feb; 16(1):24. PubMed ID: 29415722
[TBL] [Abstract][Full Text] [Related]
16. Impact of hepatectomy margin on survival following resection of colorectal metastasis: the role of adjuvant therapy and its effects.
Mbah NA; Scoggins C; McMasters K; Martin R
Eur J Surg Oncol; 2013 Dec; 39(12):1394-9. PubMed ID: 24084087
[TBL] [Abstract][Full Text] [Related]
17. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.
Kornprat P; Jarnagin WR; Gonen M; DeMatteo RP; Fong Y; Blumgart LH; D'Angelica M
Ann Surg Oncol; 2007 Mar; 14(3):1151-60. PubMed ID: 17195913
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).
Dhir M; Zenati MS; Jones HL; Bartlett DL; Choudry MHA; Pingpank JF; Holtzman MP; Bahary N; Hogg ME; Zeh HJ; Geller DA; Wallis Marsh J; Tsung A; Zureikat AH
Ann Surg Oncol; 2018 Feb; 25(2):550-557. PubMed ID: 29181682
[TBL] [Abstract][Full Text] [Related]
19. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
20. Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis.
Takahashi S; Konishi M; Kinoshita T; Gotohda N; Kato Y; Saito N; Sugito M; Yoshino T
J Gastrointest Surg; 2013 May; 17(5):939-48. PubMed ID: 23400510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
